Locked nucleic acids (LNAs) are synthetic nucleic acid analogs that bind to complementary target molecules (DNA, RNA or LNA) with very high affinity. At the same time, this binding affinity is decreased substantially when the hybrids thus formed contain even a single mismatched base pair. We have exploited these properties of LNA probes to develop a new method for single nucleotide polymorphism genotyping. In this method, very short (hexamer or heptamer) LNA probes are labeled with either rhodamine or hexachlorofluorescein (HEX), and their hybridization to target DNAs is followed by measuring the fluorescence polarization (FP) of the dyes. The formation of perfectly complementary double-stranded hybrids gives rise to significant FP increases, whereas the presence of single mismatches results in very small or no changes of this parameter. Multiplexing of the assay can be achieved by using differentially labeled wild-type and mutant specific probes in the same solution. The method is homogeneous, and because of the use of extremely short LNA probes, the generation of a universal set of genotyping reagents is possible.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC137436PMC
http://dx.doi.org/10.1093/nar/gnf090DOI Listing

Publication Analysis

Top Keywords

lna probes
16
single nucleotide
8
nucleotide polymorphism
8
polymorphism genotyping
8
locked nucleic
8
nucleic acid
8
fluorescence polarization
8
lna
5
probes
5
single
4

Similar Publications

Analyte and probe melting temperature guided method development strategy for hybridization LC-MS/MS quantification of siRNAs.

J Pharm Biomed Anal

January 2025

Drug Metabolism and Pharmacokinetics, Biogen, 225 Binney St, Cambridge, MA 02142, USA. Electronic address:

Small interfering RNA (siRNA) is a novel class of double-stranded oligonucleotide therapeutics rapidly growing in drug research and development. Accurate, sensitive, and reliable quantification of siRNA analytes in biological samples is required to study their pharmacokinetics, toxicokinetics, and biodistribution. Hybridization LC-MS/MS can achieve highly sensitive and specific bioanalysis of single-stranded oligonucleotides, e.

View Article and Find Full Text PDF

Development of robust oligonucleotide-based probe technologies, capable of recognizing specific regions of double-stranded DNA (dsDNA) targets, continues to attract considerable attention due to the promise of tools for modulation of gene expression, diagnostic agents, and new modalities against genetic diseases. Our laboratory pursues the development of various strand-invading probes. These include Invader probes, , double-stranded oligonucleotide probes with one or more +1 interstrand zipper arrangements of intercalator-functionalized nucleotides like 2'--(pyren-1-yl)methyl-RNA monomers, and chimeric Invader/γPNA probes, , heteroduplex probes between individual Invader strands and complementary γPNA strands.

View Article and Find Full Text PDF

MicroRNAs (miRNAs) have emerged as essential biomarkers for disease diagnosis, and several techniques are available to determine type 2 diabetes (T2D) relevant miRNAs. However, detecting circulating miRNAs can be challenging due to their small size, low abundance, and high sequence similarity, often requiring sensitive detection approaches combined with additional amplification processes. Laser-induced fluorescence (LIF) is a classic analytical method suitable for sensitively detecting trace amounts of nucleotide acid.

View Article and Find Full Text PDF

Background: microRNAs (miRNAs) were recognized as a promising source of diagnostic biomarker. Herein, we aim to evaluate the performance of an ultrasensitive method for detecting serum miRNAs using single molecule arrays (Simoa).

Methods: In this study, candidate miRNAs were trained and tested by RT-qPCR in a cohort of PTB patients.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional Sanger sequencing struggles with a 5%-20% wild-type mutation detection rate, which isn't sensitive enough for these needs.
  • Newer techniques like Blocker Displacement Amplification (BDA) and others help enhance sensitivity by targeting and blocking wild-type mutations, enabling the detection of low-frequency mutations, such as the RHOA G17V mutation, at 0.5% sensitivity for better MRD monitoring of angioimmunoblastic T-cell lymphoma.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!